Skip to Main Content

Paper Details

A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer.
Breast Cancer Res Treat
83
2013
Author NameAffiliation
Cynthia X MaWashington University School of Medicine
  • 1 - 1

Datasets

Release 1.2